Improving access to innovative cancer drugs
It is essential that we can harness advances in science to bring innovative drugs to people with cancer.
Our 2018 drug access report, From Patent to Patient, highlights the progress that is being made with discovering exciting new cancer medicines. But it also draws attention to key challenges that will need to be overcome to ensure more patients can benefit from these advances.
In our new Cancer drug manifesto we call for action to speed up access to innovative cancer drugs and propose a number of ways we can ensure the most innovative new cancer drugs are available as quickly as possible to all the patients who would benefit from them.
Download drug manifesto (PDF, 169KB)